Related references
Note: Only part of the references are listed.Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4
Daniel J. Wolter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Carbapenem-hydrolysing β-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil
Gisele Peirano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)
H. C. Maltezou et al.
JOURNAL OF INFECTION (2009)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae (vol 45, pg 1151, 2001)
Hesna Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France
Stephanie Petrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene
Thierry Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Isolation of imipenem-resistant Enterobacter species:: Emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom
Neil Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemases
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1
Laurent Dortet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey
Tom Chiang et al.
MICROBIAL DRUG RESISTANCE (2007)
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital
Azita Leavitt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China
Ze-Qing Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France
T Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor
A Bonnefoy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
